Klein WL, Krafft GA, Finch CE (2001) Targeting small Abeta oligomers: the solution to an Alzheimer’s disease conundrum? Trends Neurosci 24:219–224. https://doi.org/10.1016/s0166-2236(00)01749-5
Article CAS PubMed Google Scholar
Wang Y, Mandelkow E (2016) Tau in physiology and pathology. Nat Rev Neurosci 17:5–21. https://doi.org/10.1038/nrn.2015.1
Article CAS PubMed Google Scholar
Imahori K, Uchida T (1997) Physiology and pathology of tau protein kinases in relation to Alzheimer’s disease. J Biochem 121:179–188
Ferreira SA, Romero-Ramos M (2018) Microglia response during Parkinson’s disease: alpha-synuclein intervention. Front Cell Neurosci 12:247. https://doi.org/10.3389/fncel.2018.00247
Article CAS PubMed PubMed Central Google Scholar
Chen JX, Yan SS (2010) Role of mitochondrial amyloid-beta in Alzheimer’s disease. J Alzheimers Dis 20(Suppl 2):S569–S578. https://doi.org/10.3233/JAD-2010-100357
Article CAS PubMed Google Scholar
Tiwari S, Atluri V, Kaushik A et al (2019) Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomed 14:5541–5554. https://doi.org/10.2147/IJN.S200490
Crews L, Masliah E (2010) Molecular mechanisms of neurodegeneration in Alzheimer’s disease. Hum Mol Genet 19:R12–R20. https://doi.org/10.1093/hmg/ddq160
Article CAS PubMed PubMed Central Google Scholar
Galasko D, Hansen LA, Katzman R et al (1994) clinical-neuropathological correlations in Alzheimer’s disease and related dementias. Arch Neurol 51:888–895. https://doi.org/10.1001/archneur.1994.00540210060013
Article CAS PubMed Google Scholar
Ittner LM, Ke YD, Delerue F et al (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer’s disease mouse models. Cell 142:387–397. https://doi.org/10.1016/j.cell.2010.06.036
Article CAS PubMed Google Scholar
Bassil F, Brown HJ, Pattabhiraman S et al (2020) Amyloid-Beta (Aβ) plaques promote seeding and spreading of alpha-synuclein and tau in a mouse model of lewy body disorders with Aβ pathology. Neuron 105:260–275. https://doi.org/10.1016/j.neuron.2019.10.010
Article CAS PubMed Google Scholar
Lewis J, Dickson DW, Lin WL et al (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487–1491. https://doi.org/10.1126/science.1058189
Article CAS PubMed Google Scholar
Götz J, Chen F, Van Dorpe J et al (2001) Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils. Science 293:1491–1495. https://doi.org/10.1126/science.1062097
Klinkert M, Felleisen R, Link G et al (1989) Primary structures of Sm31/32 diagnostic proteins of Schistosoma mansoni and their identification as proteases. Mol Biochem Parasitol 33:113–122. https://doi.org/10.1016/0166-6851(89)90025-X
Article CAS PubMed Google Scholar
Hara-Nishimura I, Inoue K, Nishimura M (1991) A unique vacuolar processing enzyme responsible for conversion of several proprotein precursors into the mature forms. FEBS Lett 294:89–93. https://doi.org/10.1016/0014-5793(91)81349-d
Article CAS PubMed Google Scholar
Zhang Z, Song M, Liu X et al (2015) Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease. Nat Commun 6:8762. https://doi.org/10.1038/ncomms9762
Article CAS PubMed Google Scholar
Zhang Z, Song M, Liu X et al (2014) Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer’s disease. Nat Med 20:1254–1262. https://doi.org/10.1038/nm.3700
Article CAS PubMed PubMed Central Google Scholar
Basurto-Islas G, Grundke-Iqbal I, Tung YC et al (2013) Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease. J Biol Chem 288:17495–17507. https://doi.org/10.1074/jbc.M112.446070
Article CAS PubMed PubMed Central Google Scholar
Ghosh D, Mehra S, Sahay S et al (2017) α-synuclein aggregation and its modulation. Int J Biol Macromol 100:37–54. https://doi.org/10.1016/j.ijbiomac.2016.10.021
Article CAS PubMed Google Scholar
Hunn BH, Cragg SJ, Bolam JP et al (2015) Impaired intracellular trafficking defines early Parkinson’s disease. Trends Neurosci 38:178–188. https://doi.org/10.1016/j.tins.2014.12.009
Article CAS PubMed PubMed Central Google Scholar
Burre J, Sharma M, Sudhof TC (2018) Cell Biology and Pathophysiology of alpha-Synuclein. Cold Spring Harb Perspect Med. https://doi.org/10.1101/cshperspect.a024091
Article PubMed PubMed Central Google Scholar
Nguyen M, Wong YC, Ysselstein D et al (2019) Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson’s disease. Trends Neurosci 42:140–149. https://doi.org/10.1016/j.tins.2018.11.001
Article CAS PubMed Google Scholar
Hallacli E, Kayatekin C, Nazeen S et al (2022) The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability. Cell 185:2035–2056. https://doi.org/10.1016/j.cell.2022.05.008
Article CAS PubMed PubMed Central Google Scholar
Sigurdson CJ, Bartz JC, Glatzel M (2019) Cellular and molecular mechanisms of prion disease. Annu Rev Pathol 14:497–516. https://doi.org/10.1146/annurev-pathmechdis-012418-013109
Article CAS PubMed Google Scholar
Vaquer-Alicea J, Diamond MI (2019) Propagation of protein aggregation in neurodegenerative diseases. Annu Rev Biochem 88:785–810. https://doi.org/10.1146/annurev-biochem-061516-045049
Article CAS PubMed Google Scholar
Soto C, Pritzkow S (2018) Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci 21:1332–1340. https://doi.org/10.1038/s41593-018-0235-9
Article CAS PubMed PubMed Central Google Scholar
Peng C, Trojanowski JQ, Lee VM (2020) Protein transmission in neurodegenerative disease. Nat Rev Neurol 16:199–212. https://doi.org/10.1038/s41582-020-0333-7
Article CAS PubMed PubMed Central Google Scholar
Costanzo M, Abounit S, Marzo L et al (2013) Transfer of polyglutamine aggregates in neuronal cells occurs in tunneling nanotubes. J Cell Sci 126:3678–3685. https://doi.org/10.1242/jcs.126086
Article CAS PubMed Google Scholar
Abounit S, Wu JW, Duff K et al (2016) Tunneling nanotubes: a possible highway in the spreading of tau and other prion-like proteins in neurodegenerative diseases. Prion 10:344–351. https://doi.org/10.1080/19336896.2016.1223003
Comments (0)